# US Neurology Devices Market > US Neurology Devices Market Research Report By Product Type (neurostimulation, interventional neurology, csf management, neurosurgery devices) and By End User (hospitals & clinics, specialty center) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 7.3% - **2024:** $ 3,800 Million - **2025:** $ 4,077.4 Million - **2035:** $ 8,250 Million - **Key Players:** Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), NeuroPace (US), Natus Medical (US), Stryker (US), LivaNova (GB), ElectroCore (US), Cerenovus (US) **Report ID:** MRFR/HC/17922-HCR · **Pages:** 100 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-neurology-devices-market-19469 --- ## Market Summary ## **US Neurology Devices Market Overview** US Neurology Devices Market Research Report: By Product Type (neurostimulation, interventional neurology, csf management, neurosurgery devices) and  By End User (hospitals & clinics, specialty center)  - Forecast to 2035. ### **Key US Neurology Devices Market Trends Highlighted** Additionally, increased funding for research and development from both private and public sectors is promoting innovation in neurology devices, contributing to market expansion. Opportunities in the US market include the development of minimally invasive devices and [telemedicine](../../../reports/telemedicine-market-2216) solutions. The ongoing adoption of digital health technologies is transforming how healthcare providers approach treatment and monitoring of neurological conditions. This trend creates opportunities for companies to develop products that improve patient outcomes while reducing costs. Furthermore, there is a significant push towards integration of artificial intelligence in neurology devices, which can enhance diagnostic accuracy and treatment personalization. Recent trends emphasize the importance of regulatory support in speeding up product approvals. The US Food and Drug Administration has been issuing guidelines to facilitate quicker access to neurology devices for patients, encouraging market players to invest in innovative products. The increasing awareness about mental health and neurological disorders is also driving interest in therapy devices and supportive technologies aimed at improving the quality of life for affected individuals. As these trends continue to evolve, the US neurology devices market is poised for dynamic growth, enhancing the future of neurological care. Source Primary Research, Secondary Research, MRFR Database and Analyst Review ## **US Neurology Devices Market Drivers** ### **Rising Prevalence of Neurological Disorders** The increasing prevalence of neurological disorders such as Alzheimer's disease, Parkinson's disease, and epilepsy in the United States is a major driver for the US Neurology Devices Market Industry. According to the Alzheimer's Association, approximately 6.2 million Americans age 65 and older are living with Alzheimer's disease in 2021, and this number is projected to rise to 12.7 million by 2050. This growing patient population enhances the demand for innovative neurology devices such as electroencephalography (EEG) devices and neuromodulation devices, which are crucial for diagnosis and treatment. Leading organizations like Medtronic and Boston Scientific are focusing on advancing technology in neurology devices to cater to this increasing market demand. Furthermore, the National Institute of Neurological Disorders and Stroke reported that nearly 1 in 6 people in the United States will have a neurological condition at some point in their lives, indicating a sustained growth potential for neurology device manufacturers. ### **Technological Advancements in Neurology Devices** The US Neurology Devices Market Industry is significantly benefitting from rapid technological advancements in the design and functionality of neurology devices. Innovation such as the introduction of less invasive techniques and wearable monitoring devices has transformed patient care. The Food and Drug Administration has approved numerous new devices and technologies over the past few years, which has enabled better diagnosis, monitoring, and treatment of neurological disorders. A prominent example includes the approval of the NeuroPace RNS System, which was designed for epilepsy management, reflecting a trend toward precision medicine. Major manufacturers are investing heavily in Research and Development, with companies like Abbott Laboratories allocating significant proportions of their revenue to innovations that drive market growth. ### **Increased Investment in Healthcare Infrastructure** The US government and private sector investments in healthcare infrastructure play a crucial role in the growth of the US Neurology Devices Market Industry. The Centers for Medicare and Medicaid Services have been expanding coverage for neurological services, encouraging hospitals and clinics to adopt advanced neurology devices. A notable example is the recent legislation aimed at increasing funding for mental health services and neurology care as part of the American Rescue Plan Act. This increased focus on healthcare infrastructure and patient access to quality care has stimulated demand for neurology devices. As more facilities upgrade their equipment, companies such as Siemens Healthineers and GE Healthcare are poised to benefit from rising sales in imaging and monitoring devices essential for effective neurological patient management. ### **Growing Aging Population** The demographic shift in the United States toward an older population is a significant driver for the US Neurology Devices Market Industry. According to the U.S. Census Bureau, the population aged 65 and older is projected to reach 80 million by 2040, significantly increasing the number of individuals at risk for neurological disorders. This demographic change is leading to heightened demand for devices used in the diagnosis and treatment of age-related neurological conditions. Companies in the market are recognizing this trend and strategizing their product offerings to meet the needs of this growing segment. The advanced medical technology and functional safety standards are becoming crucial as manufacturers, including Philips Healthcare, continue to develop devices addressing the specific healthcare requirements of the elderly population. ## **US Neurology Devices Market Segment Insights** ### **Neurology Devices Market Product Type Insights** Interventional neurology is another noteworthy area within the US Neurology Devices Market, characterized by its focus on minimally invasive surgical procedures aimed at the treatment of various neurological conditions such as stroke and vascular disorders. This segment benefits from technological advancements, including improved imaging techniques and robotic assistance, allowing for increased precision and improved patient recovery times. The growing prevalence of vascular diseases in the US population further highlights the importance of interventional neurology in addressing critical health challenges. Cerebrospinal fluid (CSF) management devices, which are essential for treating conditions that affect the flow of cerebrospinal fluid, also play a significant role in the market. These devices are crucial for patients suffering from conditions such as hydrocephalus, where the abnormal accumulation of CSF can lead to increased intracranial pressure. The increasing incidence of such neurological disorders is driving continued innovation and adoption of CSF management solutions, ensuring better long-term outcomes for patients. Neurosurgery devices encompass a range of tools employed during surgical procedures aimed at treating brain and spinal cord conditions. As advancements in surgical techniques and technologies continue to evolve, neurosurgery devices are becoming more sophisticated, allowing for less invasive procedures that are crucial for patient safety and recovery. This segment significantly benefits from the integration of enhanced imaging systems and navigational tools, improving surgical accuracy and procedural success rates. Overall, the Product Type segment within the US Neurology Devices Market reflects a complex interplay of innovations spanning neurostimulation, interventional neurology, CSF management, and neurosurgery devices. Each niche segment is driven by distinct trends and technological advancements aimed at improving neurological health, thereby meeting the increasing demand for comprehensive treatment options within the clinical setting. The population's growing awareness of neurological disorders, combined with ongoing Research and Development, is expected to further propel market growth, making it a vital area of focus within the broader healthcare landscape. Source Primary Research, Secondary Research, MRFR Database and Analyst Review ### **Neurology Devices Market End User Insights** The rising prevalence of neurological diseases necessitates specialized services, leading to an increased demand for innovative devices. Trends such as technological advancements and the integration of telemedicine within these facilities are bolstering market growth. Additionally, the shift towards minimally invasive procedures and outpatient care is indicative of a fundamental transformation in the treatment paradigms, fostering greater efficiency and patient satisfaction. As neurology continues to evolve, these end users emerge as essential contributors to the US Neurology Devices Market, adapting to meet the complexities of neurological care in an ever-growing landscape. ## **US Neurology Devices Market Key Players and Competitive Insights** The US Neurology Devices Market is characterized by a rapidly evolving landscape marked by advancements in technology, a focus on patient-centric solutions, and the increasing prevalence of neurological disorders. Competition within this market is fierce, driven by the need for innovative treatments and diagnostic tools that can improve patient outcomes. Companies are fostering collaborations with healthcare providers and engaging in strategic partnerships to enhance their market positions. Key factors influencing this competition include the regulatory environment, reimbursement policies, and ongoing research and development initiatives aimed at addressing unmet medical needs. Market stakeholders are also paying attention to shifting consumer preferences towards minimally invasive procedures and the integration of digital health technologies, which significantly impact product development and marketing strategies. Integra LifeSciences has established a significant presence within the US Neurology Devices Market, leveraging its extensive expertise in neurosurgery and neurocritical care. Known for its innovative neurocritical care solutions and surgical products, Integra LifeSciences has focused on developing high-quality devices that enhance surgical precision and safety. The company’s strength lies in its strong research and development pipeline, which enables it to introduce cutting-edge products that align with evolving clinical practices. Furthermore, the robust distribution network and committed customer service have solidified its position in the market, allowing Integra LifeSciences to respond effectively to the needs of healthcare professionals and institutions across the United States. TheraNest operates within the US Neurology Devices Market, offering a range of products and services aimed at improving clinical efficiency in mental health and neurological therapy settings. The company focuses on providing robust solutions that enhance data management and treatment accessibility for practitioners. TheraNest's key offerings include software solutions designed to streamline patient management and documentation, reflecting its commitment to supporting healthcare providers in delivering efficient care. The company has strengthened its market presence through strategic partnerships and acquisitions that allow it to expand its portfolio and enhance service delivery. TheraNest’s emphasis on user-friendly technology and integration capabilities has positioned it well amidst its competitors, making it a noteworthy entity in the realm of neurological devices tailored for the US market. ### **Key Companies in the US Neurology Devices Market Include** ## **US Neurology Devices Market Industry Developments** The US Neurology Devices Market has witnessed significant developments in recent months, with companies like Medtronic and Boston Scientific making strides in innovative treatments for neurological disorders. Integra LifeSciences announced the expansion of its neurosurgical product line to enhance patient outcomes in July 2023. Concurrently, Biogen's strategic initiatives have focused on the development of therapies for neurodegenerative diseases, showcasing their commitment to Research and Development. Additionally, in August 2023, Abbott Laboratories received FDA approval for a new neurostimulation device aimed at treating chronic pain. The market has experienced increased investments, particularly in NeuroSigma, which recently launched a groundbreaking device for managing epilepsy. In terms of mergers and acquisitions, there were no significant public mergers or acquisitions reported for these companies in the recent timeframe. Over the past two to three years, the market has shown continuous growth, driven by technological advancements and escalating incidences of neurological disorders, thereby raising the valuation of leading companies such as Stryker and Johnson and Johnson. This growth underscores the importance of innovation and collaboration in the evolving landscape of neurological healthcare in the United States. ## **Neurology Devices Market Segmentation Insights** ### **Neurology Devices Market Product Type Outlook** ### **Neurology Devices Market End User Outlook** ## Market Drivers ### Rising Incidence of Neurological Disorders The increasing prevalence of neurological disorders in the US is a primary driver for the neurology devices market. Conditions such as Alzheimer's disease, Parkinson's disease, and epilepsy are becoming more common, affecting millions of individuals. According to the CDC, approximately 1 in 6 adults in the US experience some form of neurological condition. This growing patient population necessitates advanced diagnostic and therapeutic devices, thereby propelling market growth. The neurology devices market is expected to witness substantial expansion as healthcare providers seek innovative solutions for effective management of these disorders. Furthermore, the aging population, which is more susceptible to neurological diseases, adds to the demand for specialized devices. As a result, the neurology devices market is likely to experience a compound annual growth rate (CAGR) of around 8% over the next few years. ### Technological Innovations in Device Development Technological advancements play a crucial role in shaping the neurology devices market. Innovations such as neurostimulation devices, advanced imaging technologies, and wearable monitoring systems are revolutionizing patient care. For instance, the integration of artificial intelligence (AI) in diagnostic tools enhances accuracy and efficiency, leading to better patient outcomes. The market for neurostimulation devices alone is projected to reach $8 billion by 2026, reflecting a growing trend towards minimally invasive procedures. Additionally, the development of portable and user-friendly devices is making neurological assessments more accessible to patients and healthcare providers alike. These innovations not only improve the quality of care but also drive competition among manufacturers, further stimulating growth in the neurology devices market. ### Increased Investment in Research and Development Investment in research and development (R&D) is a significant driver of the neurology devices market. Both public and private sectors are allocating substantial funds to explore new technologies and treatment modalities for neurological disorders. The National Institutes of Health (NIH) has reported a steady increase in funding for neurological research, which is expected to exceed $2 billion in 2025. This influx of capital fosters innovation and encourages the development of cutting-edge devices that can address unmet medical needs. As new therapies and devices emerge from R&D efforts, the neurology devices market is likely to expand, offering a wider array of solutions for healthcare providers. Furthermore, collaborations between academic institutions and industry players are enhancing the pace of innovation, thereby contributing to market growth. ### Supportive Regulatory Environment for Device Approval A supportive regulatory environment is essential for the growth of the neurology devices market. The US Food and Drug Administration (FDA) has streamlined the approval process for innovative medical devices, encouraging manufacturers to bring new products to market more efficiently. This regulatory support fosters innovation and allows for quicker access to advanced therapies for patients. The FDA's initiatives, such as the Breakthrough Devices Program, aim to expedite the development and review of devices that address unmet medical needs in neurology. As a result, the neurology devices market is likely to see an influx of new products, enhancing treatment options for patients and driving overall market growth. The favorable regulatory landscape not only benefits manufacturers but also ensures that patients receive timely access to cutting-edge technologies. ### Growing Awareness and Education on Neurological Health Raising awareness about neurological health is becoming increasingly important in the US, driving demand for the neurology devices market. Public health campaigns and educational initiatives are informing individuals about the signs and symptoms of neurological disorders, leading to earlier diagnosis and treatment. As awareness increases, more patients are seeking medical attention, which in turn boosts the demand for diagnostic and therapeutic devices. The neurology devices market is likely to benefit from this trend, as healthcare providers are prompted to invest in advanced technologies to meet the needs of a more informed patient population. Additionally, educational programs aimed at healthcare professionals are enhancing their ability to recognize and manage neurological conditions effectively, further supporting market growth. ## Future Outlook The [Neurology Devices Market](https://www.marketresearchfuture.com/reports/neurology-devices-market-9768) is projected to grow at a 7.3% CAGR from 2025 to 2035, driven by technological advancements, increasing neurological disorders, and rising healthcare expenditure. **New opportunities:** - Development of AI-driven diagnostic tools for early detection of neurological conditions. Expansion of telehealth services for remote monitoring of patients with neurological disorders. Investment in portable neuromodulation devices for at-home treatment options. By 2035, the neurology devices market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Product: Neurostimulation (Largest) vs. Interventional Neurology (Fastest-Growing) In the US neurology devices market, Neurostimulation holds the largest share, showcasing its dominance and widespread application in treating various neurological disorders. Following closely is Interventional Neurology, which, while not as large, is gaining rapid traction due to increasing prevalence of neurovascular diseases and advancements in minimally invasive surgical techniques. The growth trends within these segments highlight a dynamic landscape. Neurostimulation is bolstered by an expanding range of applications from chronic pain management to treatment for epilepsy. Interventional Neurology, on the other hand, is experiencing exponential growth driven by a rise in endovascular procedures and technological innovations that improve patient outcomes and reduce recovery times. Neurostimulation (Dominant) vs. Interventional Neurology (Emerging) Neurostimulation is characterized by its established presence and effectiveness in managing chronic conditions, which makes it the dominant segment of the US neurology devices market. Its application spectrum—from deep brain stimulation to spinal cord stimulation—positions it as a vital component of modern neurological care. Conversely, Interventional Neurology represents an emerging segment that focuses on treating conditions through catheter-based therapies, emphasizing innovation and less invasive approaches. The latter is gaining popularity due to its capability to reduce surgical risks, shorten recovery times, and offer effective treatment for conditions like aneurysms and arteriovenous malformations. ### By End User: Hospitals & Clinics (Largest) vs. Specialty Center (Fastest-Growing) Hospitals & Clinics dominate the US neurology devices market, accounting for a substantial share due to their extensive healthcare infrastructure and high patient volume. This segment benefits from advanced medical technologies and equipment readily available, making it the primary choice for neurology-related treatments. Specialty Centers, on the other hand, are significantly gaining traction, exhibiting a rapid increase in demand as more patients seek specialized neurological care, resulting in a competitive landscape that complements traditional hospitals. The growth trends in the end user segment are primarily driven by an increasing prevalence of neurological disorders in the US, necessitating advanced treatment options. Additionally, the rising patient awareness and the demand for specialized care at Specialty Centers contribute to their rapid growth. Innovations in neurology devices and enhanced reimbursement policies are further fueling this expansion, presenting substantial opportunities for both Hospitals & Clinics and Specialty Centers in the evolving landscape of neurological care. Hospitals & Clinics (Dominant) vs. Specialty Center (Emerging) Hospitals & Clinics represent the dominant force in the US neurology devices market, characterized by their comprehensive service offerings and access to a broad range of patients. Equipped with cutting-edge technology and staffed by experienced professionals, these institutions are pivotal for treating complex neurological conditions. Conversely, Specialty Centers are emerging as vital players, focusing on specific neurological disorders and providing tailored treatment plans. Their specialized approach attracts patients seeking advanced, targeted care, leading to a shift in patient preference towards these centers. This dual dynamic between the dominant and emerging segments emphasizes the need for a diversified strategy in addressing the varied demands of patients. ## Competitive Benchmarking The neurology devices market is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of neurological disorders. Key players such as Medtronic (US), Boston Scientific (US), and Abbott Laboratories (US) are at the forefront, focusing on innovation and strategic partnerships to enhance their market positions. Medtronic (US) emphasizes its commitment to developing cutting-edge neurostimulation devices, while Boston Scientific (US) is expanding its portfolio through acquisitions and collaborations aimed at enhancing its product offerings. Abbott Laboratories (US) is leveraging its expertise in neuromodulation to introduce novel therapies, thereby shaping the competitive environment through a blend of innovation and strategic alignment.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies like Medtronic (US) and Boston Scientific (US) suggests a trend towards consolidation, as these firms seek to leverage economies of scale and enhance their competitive edge. In October Medtronic (US) announced the launch of its latest deep brain stimulation system, which integrates advanced AI algorithms to personalize treatment for patients with Parkinson's disease. This strategic move not only underscores Medtronic's commitment to innovation but also positions the company as a leader in the neuromodulation space, potentially enhancing patient outcomes and driving market growth. In September Boston Scientific (US) completed the acquisition of a promising neurotechnology startup, which specializes in minimally invasive devices for treating chronic pain. This acquisition is likely to bolster Boston Scientific's product portfolio and expand its reach in the neurology devices market, reflecting a strategic focus on enhancing its capabilities in pain management solutions. In August Abbott Laboratories (US) launched a new remote monitoring platform for its neuromodulation devices, aimed at improving patient engagement and adherence to therapy. This initiative highlights Abbott's strategic emphasis on digital health solutions, which may enhance patient outcomes and streamline care delivery, thereby reinforcing its competitive position in the market. As of November the neurology devices market is witnessing trends such as digitalization, AI integration, and a growing emphasis on sustainability. Strategic alliances among key players are shaping the competitive landscape, fostering innovation and collaboration. The shift from price-based competition to a focus on technological advancement and supply chain reliability is becoming increasingly evident. Companies that prioritize innovation and adaptability are likely to thrive in this evolving market, as they respond to the changing needs of healthcare providers and patients alike. ## Recent News & Developments The US Neurology Devices Market has witnessed significant developments in recent months, with companies like Medtronic and Boston Scientific making strides in innovative treatments for neurological disorders. Integra LifeSciences announced the expansion of its neurosurgical product line to enhance patient outcomes in July 2023. Concurrently, Biogen's strategic initiatives have focused on the development of therapies for neurodegenerative diseases, showcasing their commitment to Research and Development. Additionally, in August 2023, Abbott Laboratories received FDA approval for a new neurostimulation device aimed at treating chronic pain. The market has experienced increased investments, particularly in NeuroSigma, which recently launched a groundbreaking device for managing epilepsy. In terms of mergers and acquisitions, there were no significant public mergers or acquisitions reported for these companies in the recent timeframe. Over the past two to three years, the market has shown continuous growth, driven by technological advancements and escalating incidences of neurological disorders, thereby raising the valuation of leading companies such as Stryker and Johnson and Johnson. This growth underscores the importance of innovation and collaboration in the evolving landscape of neurological healthcare in the United States. ## Report Scope | MARKET SIZE 2024 | 3800.0(USD Million) | | --- | --- | | MARKET SIZE 2025 | 4077.4(USD Million) | | MARKET SIZE 2035 | 8250.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.3% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), NeuroPace (US), Natus Medical (US), Stryker (US), LivaNova (GB), ElectroCore (US), Cerenovus (US) | | Segments Covered | Product, End User | | Key Market Opportunities | Advancements in neurostimulation technologies enhance treatment options in the neurology devices market. | | Key Market Dynamics | Technological advancements drive innovation in neurology devices, enhancing treatment options and patient outcomes in the US. | | Countries Covered | US | ## Frequently Asked Questions **Q: What is the current valuation of the US neurology devices market?** A: The market valuation was $3800.0 Million in 2024. **Q: What is the projected market size for the US neurology devices market by 2035?** A: The projected valuation for 2035 is $8250.0 Million. **Q: What is the expected CAGR for the US neurology devices market during the forecast period 2025 - 2035?** A: The expected CAGR is 7.3% during the forecast period. **Q: Which segments are included in the US neurology devices market?** A: Key segments include Neurostimulation, Interventional Neurology, CSF Management, and Neurosurgery Devices. **Q: What were the market values for Neurostimulation in 2024?** A: The market value for Neurostimulation was $1200.0 Million in 2024. **Q: How much is the Interventional Neurology segment projected to grow by 2035?** A: The Interventional Neurology segment is projected to grow to $2000.0 Million by 2035. **Q: What is the market value for CSF Management in 2024?** A: The market value for CSF Management was $600.0 Million in 2024. **Q: Which companies are leading the US neurology devices market?** A: Key players include Medtronic, Boston Scientific, Abbott Laboratories, and NeuroPace. **Q: What is the projected market value for Neurosurgery Devices by 2035?** A: The projected market value for Neurosurgery Devices is $2250.0 Million by 2035. **Q: What are the end-user segments in the US neurology devices market?** A: End-user segments include Hospitals & Clinics and Specialty Centers. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-neurology-devices-market-19469*